Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neoasia Vietnam is a leading distributor of medical aesthetic and dermatological products, serving as a key regional branch of the Singapore-based Neoasia Group. The company specializes in the distribution, marketing, and clinical support of advanced skincare technologies, medical devices, and injectable treatments from global manufacturers. Their portfolio includes prominent brands such as Profhilo, Heliocare, Neostrata, and Revitalash, catering to aesthetic clinics and healthcare professionals across Vietnam. In addition to product supply, Neoasia Vietnam operates a dedicated training academy to ensure practitioners are proficient in the latest aesthetic techniques and safety protocols. The company plays a vital role in bridging international innovation with the rapidly growing Vietnamese aesthetic market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neoasia Vietnam.